Oncotarget

Research Papers:

MicroRNA-552 enhances metastatic capacity of colorectal cancer cells by targeting a disintegrin and metalloprotease 28

Jian Wang, Hai Li, Yong Wang, Libin Wang, Xiurui Yan, Dong Zhang, Xiaoqiang Ma, Yong Du, Xiaoming Liu and Yinxue Yang _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:70194-70210. https://doi.org/10.18632/oncotarget.12169

Metrics: PDF 2167 views  |   HTML 2398 views  |   ?  


Abstract

Jian Wang1,2,*, Hai Li3,*, Yong Wang1,2, Libin Wang2, Xiurui Yan2, Dong Zhang3, Xiaoqiang Ma3, Yong Du1, Xiaoming Liu2, Yinxue Yang1,2,3

1The general hospital, Ningxia Medical University, Yinchuan 750004, China

2Human Stem Cell Institute of the General Hospital at Ningxia Medical University, Yinchuan 750004, China

3Department of Colorectal Surgery, the General Hospital of Ningxia Medical University, Yinchuan 750004, China

*These authors contributed equally to this work

Correspondence to:

Yinxue Yang, email: nyfyyyx@126.com

Xiaoming Liu, email: liuxiaoming@nxmu.edu.cn, erc1080@163.com

Keywords: microRNAs, colorectal cancer, miR-552, antagomir, ADAM28

Received: January 25, 2016     Accepted: August 08, 2016     Published: September 21, 2016

ABSTRACT

Colorectal cancer (CRC) is one of the most common prevalent cancer types worldwide. MicroRNAs (miRNAs or miRs) have been demonstrated to play crucial roles in the development, metastasis and drug resistance of CRC. In the present study, a strikingly elevated expression of miR-552 was determined in CRC tumor tissues and cells by a miRNA profiling analysis. Importantly, the gene of A Disintegrin And Metalloprotease (ADAM) family member 28 (ADAM28) was identified as a target of miR-552, which was further validated in terms of genetic dual luciferase report assay. Furthermore, an inhibition of miR-552 in LOVE and LS174T CRC cells by transducing miR-552 inhibitor (antagomiR-552) with a lentiviral vector exhibited an ability to reduce cell proliferation, migration and clonogenicity. Moreover, both LOVO and LS174T cells stably expressing miR-552 inhibitor displayed a decreased ability to develop tumors in a murine xenograft model in vivo. In contrast, a knockdown of ADAM28 by short hairpin RNA could reverse the antagomiR-552-induced inhibition of metastatic features of CRC cells in vitro. These results suggested that miR-552 is an oncomir able to promote CRC metastasis in part through a mechanism of targeting ADAM28, which may be a novel target for CRC treatment and warrants for further investigation.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 12169